Where does the value of 'value-added' pharmaceuticals come from?

Abstract

The role of sound science, discovery, and innovation in value-added pharmaceuticals has not been sufficiently considered. This term is mainly used to define improved version of generic drugs. The concept of value-added pharmaceuticals has been picked up by different groups of companies, some are aiming to increase willingness to pay for their modified pharmaceutical products, others like generic pharmaceutical producers, try to become more innovative and less 'patent expiration-dependent'. Optimizing the existing pharmaceuticals can create competitive advantage and can strengthen the reputation and credibility of the generic pharmaceutical companies.